2024-12-26 11:45:46
Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use
Health/ 2023-07-22
Cali Biosciences Initiates Phase III Stu...

- Subjects in Herniorrhaphy Study Dosed - Successful FDA Interactions on Two Pre-clinical Pipeline Products Also Discussed

Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses
Corporate/ 2023-07-24
Nona Biosciences and Washington Universi...

CAMBRIDGE,Mass.,April 19,2023-- Nona Biosciences,a wholly-owned subsidiary of HBM Holdings Limited,committed to cutting edge technology inno...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release